Company Search:
Advanced Search
Sponsored Links
Synairgen PLC Company Snapshot
Synairgen PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Synairgen PLC with three other companies in this sector in UNITED KINGDOM : Immupharma PLC (2018 sales of £81,281.00 [US$110,888.42 ] of which 100% was Pharmaceutical Research & Development), Reneuron Group PLC (£43,000.00 [US$58,663.18 ] of which 100% was Cell-Based Therapies), and Redx Pharma PLC (£129,000.00 [US$175,989.54 ] of which 100% was pharmaceutical).

Sales Analysis.
  Stock Performance Chart for Synairgen PLC
  Stock Data: Recent Stock Performance:
  Current Price (1/8/2021): 140.00p
(Figures in Pounds Sterling)
1 Week -8.5%   13 Weeks 55.6%  
4 Weeks -17.6%   52 Weeks 2,180.8%  
Synairgen PLC Key Data:
  Ticker: SNG Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 105,000
(Year Ending Jan 2019).
Employees: 14
  Currency: Pounds Sterling Market Cap: 210,456,721
  Fiscal Yr Ends: December Shares Outstanding: 150,326,229
  Share Type: Ordinary Closely Held Shares: 14,991,351
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.